000			01805nam a2200217Ia 4500
003			OSt
005			20220322155953.0
008			210614s9999 xx 000 0 und d
020			_a 978-981-14-0191-6
020			_a9811401918
040			_cLC
100			_aAtta-ur-Rahman (Ed.)
245		0	_aFrontiers in Anti-cancer drug discovery/ _cAtta-ur-Rahman & M.Iqbal Choudhary (Ed.)
260			_aUAE
260			_bBentham Science
260			_c2019.
300			_a‎ 252 pages
440			_vVol. 10.
520			_arontiers in Anti-Cancer Drug Discovery is a book series devoted to publishing the latest advances in anti-cancer drug design and discovery. In each volume, eminent scientists contribute reviews relevant to all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The book series should prove to be of interest to all pharmaceutical scientists involved in research in anti-cancer drug design and discovery. The book series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field. The tenth volume of the series features chapters covering the following topics: - Challenges in the Management of Hepatoblastoma - The Emerging Role of Monocarboxylate Transporter-1 in Cancer - In-vitro Anti-Proliferative Assays and Techniques Used in Pre-Clinical Anti-Cancer Drug Discovery - Recent Advances in the Development of Mesoporous Anti-Cancer Drug Nanocarriers - Polyphenols and Cancer - Glioblastoma Multiforme - Cutting Edge Targeting Strategies Utilizing Nanotechnology in Breast Cancer Therapy
942			_cBK _2lcc
999			_c157672 _d157672